Biomarkers of PEGylated Liposomal Doxorubicin-Induced Hypersensitivity Reaction in Breast Cancer Patients Based on Metabolomics

This study aimed to analyze and discuss the biomarkers of PEGylated liposomal doxorubicin (PLD) injection-induced hypersensitivity reactions (HSRs) in advanced breast cancer patients. Fourteen patients from Sun Yat-sen Memorial Hospital were included in the study between April 15th, 2020 and April 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Wei, Lai, Xiuping, Mai, Qingxiu, Ye, Suiwen, Chen, Junyi, Liu, Yanqiong, Wang, Jingshu, Li, Siming, Huang, Yanqing, Qin, Tao, Hu, Hai, Wu, Junyan, Yao, Herui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068896/
https://www.ncbi.nlm.nih.gov/pubmed/35529437
http://dx.doi.org/10.3389/fphar.2022.827446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068896/
https://www.ncbi.nlm.nih.gov/pubmed/35529437
http://dx.doi.org/10.3389/fphar.2022.827446

Ejemplares similares